Market Overview:
The global animal biological vaccine market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for animal vaccines due to the rise in zoonotic diseases and outbreaks, and technological advancements in vaccine development. In terms of type, the oral segment is expected to grow at a higher CAGR than other segments during the forecast period. This can be attributed to factors such as ease of administration and lower cost as compared with other types of vaccines. By application, livestock is expected to account for the largest share of the global animal biological vaccine market in 2018.
Product Definition:
An animal biological vaccine is a vaccine that is derived from the tissue of an animal. Animal biological vaccines are used to protect animals from diseases. The importance of animal biological vaccines is that they can help protect animals from diseases, which can then help to protect humans from those same diseases.
Oral:
Oral vaccines are those given to animals, which can be administered through the mouth. The most commonly used oral vaccine is for dogs and cats. Other types of oral vaccines include those for livestock as well as birds and reptiles. These are also known as creep or intraruminal vaccines since they are administered directly into the animal's body cavity (intradermal).
Subcutaneous:
Subcutaneous is a vaccine administration method that involves injecting the vaccine into the skin. This allows for better absorption of the vaccine by the immune system and also reduces side effects. The subcutaneous mode of vaccination is preferred in animals because it offers several advantages such as ease in handling, low risk of pathogen transmission, and minimal pain & distress to animal.
Application Insights:
The aquaculture segment accounted for the largest revenue share in 2017 and is anticipated to maintain its lead over the forecast period. The growth of this segment can be attributed to factors such as growing demand for fish, increasing concerns regarding diseases in aquafeed, and vaccine contamination. Moreover, rising awareness about vaccines among farmers is also expected to drive the market growth during the forecast period.
Livestock accounted for a significant share in 2017 owing to high consumption of vaccines by cattle & buffalos against a wide range of diseases including Foot-and-Mouth Disease (FMD), Avian Influenza (AI), classical swine fever (CSF) virus 1 & 2 infection as well as coronavirus infection among others. In addition, porcine circovirus 2&3 infections are also being targeted with great success using Ovine Orthoreovirus Vaccines (ORV).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing R&D investments by government and private entities, high animal population, and rising awareness among people for vaccination programs. Asia Pacific is projected to grow at a lucrative rate over the next eight years owing to factors such as growing economy, improving healthcare infrastructure & availability of vaccines, increase in livestock population especially cattle and buffalo numbers along with rising pet animals populations. Moreover, increasing demand for meat products from developing countries like China & India will drive this regional market further.
Growth Factors:
- Increasing demand for animal biological vaccines due to rising incidence of zoonotic diseases.
- Growing awareness about the benefits of animal biological vaccines among veterinarians and farmers.
- Technological advancements in the field of animal vaccine development and manufacturing process that is expected to result in higher efficacy and safety profiles of these products.
- Rising investments by vaccine manufacturers for research and development activities aimed at developing novel animal biological vaccines formulations 5 Increased public-private sector collaborations for accelerating the commercialization process of new veterinary biologics
Scope Of The Report
Report Attributes
Report Details
Report Title
Animal Biological Vaccine Market Research Report
By Type
Oral, Subcutaneous, Intramuscular, Others
By Application
Porcine, Poultry, Livestock, Companion Animals, Aquaculture
By Companies
Merck, Zoetis, Merial/Sanofi, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, Merck, Elanco/Eli Lilly, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken, FATRO, Vaksindo, Bio-Labs, Avimex Animal
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Animal Biological Vaccine Market Report Segments:
The global Animal Biological Vaccine market is segmented on the basis of:
Types
Oral, Subcutaneous, Intramuscular, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Porcine, Poultry, Livestock, Companion Animals, Aquaculture
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Zoetis
- Merial/Sanofi
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- Merck
- Elanco/Eli Lilly
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal
Highlights of The Animal Biological Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Subcutaneous
- Intramuscular
- Others
- By Application:
- Porcine
- Poultry
- Livestock
- Companion Animals
- Aquaculture
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Biological Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Animal Biological Vaccines are vaccines made from viruses, bacteria, or other organisms that have been killed or weakened so they cannot cause disease in humans.
Some of the major companies in the animal biological vaccine market are Merck, Zoetis, Merial/Sanofi, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, Merck, Elanco/Eli Lilly, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken, FATRO, Vaksindo, Bio-Labs, Avimex Animal.
The animal biological vaccine market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Biological Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Animal Biological Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Animal Biological Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Animal Biological Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Animal Biological Vaccine Market Size & Forecast, 2018-2028
4.5.1 Animal Biological Vaccine Market Size and Y-o-Y Growth
4.5.2 Animal Biological Vaccine Market Absolute $ Opportunity
Chapter 5 Global Animal Biological Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Animal Biological Vaccine Market Size Forecast by Type
5.2.1 Oral
5.2.2 Subcutaneous
5.2.3 Intramuscular
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Animal Biological Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Animal Biological Vaccine Market Size Forecast by Applications
6.2.1 Porcine
6.2.2 Poultry
6.2.3 Livestock
6.2.4 Companion Animals
6.2.5 Aquaculture
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Animal Biological Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Animal Biological Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Animal Biological Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Animal Biological Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Animal Biological Vaccine Market Size Forecast by Type
9.6.1 Oral
9.6.2 Subcutaneous
9.6.3 Intramuscular
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Animal Biological Vaccine Market Size Forecast by Applications
9.10.1 Porcine
9.10.2 Poultry
9.10.3 Livestock
9.10.4 Companion Animals
9.10.5 Aquaculture
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Animal Biological Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Animal Biological Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Animal Biological Vaccine Market Size Forecast by Type
10.6.1 Oral
10.6.2 Subcutaneous
10.6.3 Intramuscular
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Animal Biological Vaccine Market Size Forecast by Applications
10.10.1 Porcine
10.10.2 Poultry
10.10.3 Livestock
10.10.4 Companion Animals
10.10.5 Aquaculture
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Animal Biological Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Animal Biological Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Animal Biological Vaccine Market Size Forecast by Type
11.6.1 Oral
11.6.2 Subcutaneous
11.6.3 Intramuscular
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Animal Biological Vaccine Market Size Forecast by Applications
11.10.1 Porcine
11.10.2 Poultry
11.10.3 Livestock
11.10.4 Companion Animals
11.10.5 Aquaculture
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Animal Biological Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Animal Biological Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Animal Biological Vaccine Market Size Forecast by Type
12.6.1 Oral
12.6.2 Subcutaneous
12.6.3 Intramuscular
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Animal Biological Vaccine Market Size Forecast by Applications
12.10.1 Porcine
12.10.2 Poultry
12.10.3 Livestock
12.10.4 Companion Animals
12.10.5 Aquaculture
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Animal Biological Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Animal Biological Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Animal Biological Vaccine Market Size Forecast by Type
13.6.1 Oral
13.6.2 Subcutaneous
13.6.3 Intramuscular
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Animal Biological Vaccine Market Size Forecast by Applications
13.10.1 Porcine
13.10.2 Poultry
13.10.3 Livestock
13.10.4 Companion Animals
13.10.5 Aquaculture
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Animal Biological Vaccine Market: Competitive Dashboard
14.2 Global Animal Biological Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Zoetis
14.3.3 Merial/Sanofi
14.3.4 Boehringer Ingelheim
14.3.5 Ceva
14.3.6 CAHIC
14.3.7 HVRI
14.3.8 Ringpu Biology
14.3.9 Yebio
14.3.10 DHN
14.3.11 Merck
14.3.12 Elanco/Eli Lilly
14.3.13 Virbac
14.3.14 Jinyu Bio-Technology
14.3.15 ChengDu Tecbond
14.3.16 CAVAC
14.3.17 Kyoto Biken
14.3.18 FATRO
14.3.19 Vaksindo
14.3.20 Bio-Labs
14.3.21 Avimex Animal
